Acuta Capital Partners, LLC Bicycle Therapeutics PLC Put Options Transaction History
Acuta Capital Partners, LLC
- $70.3 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCYC
# of Institutions
104Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$122 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$51.2 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$38.8 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$29.4 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$24.7 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $334M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...